Round Hill Asset Management Q3 2022 vs. Q4 2022 13F Holdings Comparison

In the investment world, Quarterly 13F Holdings is the most comprehensive information source for institutional investors. The document is America's institutional investors' mandate for filing a report on their equity assets' holdings. One top-performing management firm in the Investment world, Round Hill Asset Management, recently filed a 13F Form for Q3 2022 and Q4 2022. This article aims to highlight Round Hill Asset Management's Q3 and Q4 2022 13F holdings Comparison.

Backstory on Round Hill Asset Management

Round Hill Asset Management is a New York-based investment firm that provides investments in music royalties and Intellectual property (IP). The company primarily assists small businesses in acquiring rights to a musician or a creative piece and generates revenue from royalties that follow them.

Round Hill Asset Management Q3 2022 vs. Q4 2022 13F Holdings Comparison

This quarter, Round Hill Asset Management made significant changes to its portfolio. Here is a highlight of the company's portfolio changes during this period:

S&P Global Inc (SPGI): Round Hill Asset Management has maintained its position in S&P Global Inc.

Moody's Corp (MCO): There was a slight decrease of 0.01% in the shares for Moody's Corp.

Amgen Inc. (AMGN): Despite a drop of 15%, Round Hill Asset Management still holds a significant position in Amgen Inc.

Merck & Co. Inc. (MRK): Round Hill Asset Management increased its position in Merck & Co. Inc. by 10%.

Comcast Corp. (CMCSA): Comcast has been a constant part of Round Hill Asset Management's portfolio, and the company maintained its position.

Walt Disney Co (DIS): In Q4 2022, Round Hill Asset Management reduced its shares for Walt Disney Co by 9%.

Pfizer Inc. (PFE): There was a 16.2 percent increase in Round Hill Asset Management's shares for Pfizer Inc.

The majority of stocks in Round Hill Asset Management's holding portfolio are from the healthcare, IT, and financial sectors. Understanding the Q3 vs. Q4 difference in the company's equity holdings, it is evident that the company has been bullish on healthcare stocks.

Conclusion

In conclusion, when it comes to investment, a decision to buy or sell requires as much information as possible, and the 13F filing is a great tool to keep track of how an institution is performing. Taking Round Hill Asset Management's Q3 2022 vs. Q4 2022 13F holdings comparison into account - the company is bullish on the Healthcare sector, with Amgen Inc.'s drop, leading the sector as the only stock with a significant turnover of 15%.